Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT07252115)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07252115 Sponsor: Beijing Friendship Hospital Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07252115 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 85 years of age.
People who have been diagnosed with a hiatal hernia (a condition where part of the stomach pushes up through the diaphragm into the chest), including any type from mild to severe.
People whose acid reflux (heartburn) symptoms have not improved after taking 40 mg of omeprazole (a common stomach acid medication) every day for 8 to 12 weeks.
People whose acid reflux has been confirmed by either a special test that measures acid levels in the food pipe over 24 hours, or by a camera examination showing inflammation in the food pipe, or both.
People whose hiatal hernia has been confirmed by both a CT scan of the abdomen and a camera examination of the stomach.

Who may not be able to join:

People who have acid reflux but do not have a hiatal hernia.
People who have a condition affecting the movement or muscle function of the food pipe (confirm with trial site).
People who have previously had surgery on the food pipe or in the upper abdomen.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 15011302788

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07252115

Sponsor: Beijing Friendship Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

Trial contact: +86 15011302788

More information: https://clinicaltrials.gov/study/NCT07252115

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 85 years of age.
People who have been diagnosed with a hiatal hernia (a condition where part of the stomach pushes up through the diaphragm into the chest), including any type from mild to severe.
People whose acid reflux (heartburn) symptoms have not improved after taking 40 mg of omeprazole (a common stomach acid medication) every day for 8 to 12 weeks.
People whose acid reflux has been confirmed by either a special test that measures acid levels in the food pipe over 24 hours, or by a camera examination showing inflammation in the food pipe, or both.
People whose hiatal hernia has been confirmed by both a CT scan of the abdomen and a camera examination of the stomach.

Who may not be able to join:

People who have acid reflux but do not have a hiatal hernia.
People who have a condition affecting the movement or muscle function of the food pipe (confirm with trial site).
People who have previously had surgery on the food pipe or in the upper abdomen.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Beijing Friendship Hospital

Registry

ClinicalTrials.gov

Start date

4 April 2024

Est. completion

30 November 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Gastrointestinal Quality of Life Index (GLQI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov